BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Perumpail BJ, Khan MA, Yoo ER, Cholankeril G, Kim D, Ahmed A. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. World J Gastroenterol 2017; 23(47): 8263-8276 [PMID: 29307986 DOI: 10.3748/wjg.v23.i47.8263]
URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8263.htm
Number Citing Articles
1
Nahum Méndez-Sánchez, Eira Cerda-Reyes, Fátima Higuera-de-la-Tijera, Ana K. Salas-García, Samantha Cabrera-Palma, Guillermo Cabrera-Álvarez, Carlos Cortez-Hernández, Luis A Pérez-Arredondo, Emma Purón-González, Edgar Coronado-Alejandro, Arturo Panduro, Heriberto Rodríguez-Hernández, Vania C. Cruz-Ramón, Alejandro Valencia-Rodríguez, Xingshun Qi, Nashla Hamdan-Pérez, Nancy E. Aguilar-Olivos, Beatriz Barranco-Fragoso, Oscar Ramírez-Pérez, Alfonso Vera-Barajas. Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitisF1000Research 2020; 9: 56 doi: 10.12688/f1000research.21918.1
2
Seonghae Yoon, Heechan Lee, Sang‐Chun Ji, Seo Hyun Yoon, Joo‐Youn Cho, Jae‐Yong Chung. Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver FunctionClinical Pharmacology in Drug Development 2021; 10(1): 68 doi: 10.1002/cpdd.790
3
Muhammad Sohaib Asghar, Maira Hassan, Uzma Rasheed, Syed Jawad Haider Kazmi, Noman A Khan, Faran Khalid, Ayesha Anum, Saira Anwar. Impact of Fasting Lipid Profile on Chronic Kidney Disease Patients Having Fatty Liver DiseaseCureus 2020;  doi: 10.7759/cureus.11146
4
Razk Abdalgwad, Mohammed F. Rafey, Siobhan Foy, Micheál Newell, Colin Davenport, Derek T. O'Keeffe, Francis M. Finucane. Long-Term Changes in Weight in Patients With Severe and Complicated Obesity After Completion of a Milk-Based Meal Replacement ProgrammeFrontiers in Nutrition 2020; 7 doi: 10.3389/fnut.2020.551068
5
Thaddeus J. Maguire, Aditya Shreenivas, William S. Rilling. Image-Guided Interventions in Oncology2020; : 81 doi: 10.1007/978-3-030-48767-6_6
6
Brian A. Telfer, Viksit Kumar, Aaron D. Aguirre, Anthony E. Samir, Laura J. Brattain. Machine Learning in Cardiovascular Medicine2021; : 177 doi: 10.1016/B978-0-12-820273-9.00008-7
7
Eric J. Hyzny, Ernest G. Chan, Matthew Morrell, Takashi Harano, Pablo G. Sanchez. A review of liver dysfunction in the lung transplant patientClinical Transplantation 2021;  doi: 10.1111/ctr.14344
8
Yi-Shu Chen, Dan Chen, Chao Shen, Ming Chen, Chao-Hui Jin, Cheng-Fu Xu, Chao-Hui Yu, You-Ming Li. A novel model for predicting fatty liver disease by means of an artificial neural networkGastroenterology Report 2021; 9(1): 31 doi: 10.1093/gastro/goaa035
9
Risa M. Wolf, Kiyoko Oshima, Joseph K. Canner, Kimberley E. Steele. Impact of a preoperative low-calorie diet on liver histology in patients with fatty liver disease undergoing bariatric surgerySurgery for Obesity and Related Diseases 2019; 15(10): 1766 doi: 10.1016/j.soard.2019.08.013
10
Mohamed I. Elsaid, You Li, Carolyn Catalano, Carlos D. Minacapelli, Kapil Gupta, Vinod K. Rustgi. Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United StatesPharmacoEconomics - Open 2021; 5(1): 89 doi: 10.1007/s41669-020-00229-4
11
Hande Erman, Engin Beydogan, Seher Irem Cetin, Banu Boyuk. Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic SyndromeMediators of Inflammation 2020; 2020: 1 doi: 10.1155/2020/3534042
12
Tao Jiang, Xiao-jing Guo, Li-ping Tu, Zhou Lu, Ji Cui, Xu-xiang Ma, Xiao-juan Hu, Xing-hua Yao, Long-tao Cui, Yong-zhi Li, Jing-bin Huang, Jia-tuo Xu. Application of computer tongue image analysis technology in the diagnosis of NAFLDComputers in Biology and Medicine 2021; 135: 104622 doi: 10.1016/j.compbiomed.2021.104622
13
Salvatore Petta, Jie Ting, Stefania Saragoni, Luca Degli Esposti, Sanatan Shreay, Maria Letizia Petroni, Giulio Marchesini. Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in ItalyNutrition, Metabolism and Cardiovascular Diseases 2020; 30(6): 1014 doi: 10.1016/j.numecd.2020.02.016
14
Idrees Suliman, Noha Abdelgelil, Farah Kassamali, Tarek I. Hassanein. The Effects of Hepatic Steatosis on the Natural History of HBV InfectionClinics in Liver Disease 2019; 23(3): 433 doi: 10.1016/j.cld.2019.05.001
15
Saleh A. Alqahtani, Pegah Golabi, James M. Paik, Brian Lam, Amir H. Moazez, Hazem A. Elariny, Zachary Goodman, Zobair M. Younossi. Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver DiseaseObesity Surgery 2021; 31(5): 2002 doi: 10.1007/s11695-020-04996-1
16
Sarayu A. Pai, Renuka P. Munshi, Falguni H. Panchal, Ila-Shruti Gaur, Snehal N. Mestry, Malvika S. Gursahani, Archana R. Juvekar. Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stressBiomedicine & Pharmacotherapy 2019; 111: 686 doi: 10.1016/j.biopha.2018.12.139
17
Yingfei Xi, Hongshan Li. Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver diseaseBiomedicine & Pharmacotherapy 2020; 121: 109609 doi: 10.1016/j.biopha.2019.109609
18
Yang Zou, Ling Zhong, Chong Hu, Guotai Sheng. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal studyLipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01419-z
19
Marleigh Hefner, Vineet Baliga, Kailinn Amphay, Daniela Ramos, Vijay Hegde. Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease PathologyFrontiers in Aging Neuroscience 2021; 13 doi: 10.3389/fnagi.2021.721858
20
Yu A. An, Shiuhwei Chen, Yingfeng Deng, Zhao V. Wang, Jan-Bernd Funcke, Manasi Shah, Bo Shan, Ruth Gordillo, Jun Yoshino, Samuel Klein, Christine M. Kusminski, Philipp E. Scherer. The mitochondrial dicarboxylate carrier prevents hepatic lipotoxicity by inhibiting white adipocyte lipolysisJournal of Hepatology 2021; 75(2): 387 doi: 10.1016/j.jhep.2021.03.006
21
Xiangmeng Chen, Teng Ma, Rowena Yip, Ponni V. Perumalswami, Andrea D. Branch, Sara Lewis, Michael Crane, David F. Yankelevitz, Claudia I. Henschke. Elevated prevalence of moderate-to-severe hepatic steatosis in World Trade Center General Responder Cohort in a program of CT lung screeningClinical Imaging 2020; 60(2): 237 doi: 10.1016/j.clinimag.2019.12.009
22
Stuart C. Gordon, Jeremy Fraysse, Suying Li, A. Burak Ozbay, Robert J. Wong. Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare PatientsAmerican Journal of Gastroenterology 2020; 115(4): 562 doi: 10.14309/ajg.0000000000000484
23
Nan Xu, Huijuan Luo, Minyao Li, Jiazhen Wu, Xue Wu, Liping Chen, Yuxuan Gan, Fengkun Guan, Mengyao Li, Ziren Su, Jiannan Chen, Yuhong Liu. β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathwayBiomedicine & Pharmacotherapy 2021; 134: 111104 doi: 10.1016/j.biopha.2020.111104
24
Tsung-Hsien Chou, Hsing-Jung Yeh, Chun-Chao Chang, Jui-Hsiang Tang, Wei-Yu Kao, I-Chia Su, Chien-Hung Li, Wei-Hao Chang, Chun-Kai Huang, Herdiantri Sufriyana, Emily Chia-Yu Su. Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liverJournal of the Chinese Medical Association 2021; 84(9): 842 doi: 10.1097/JCMA.0000000000000585
25
Rajesh Krithika, Ramtej Jayaram Verma. Hypolipidemic and Hypoglycemic Effects of Hydroalcoholic Extract of Solanum nigrum Linn. in CCl4-induced Hepatotoxicity in MiceToxicology and Environmental Health Sciences 2018; 10(5): 268 doi: 10.1007/s13530-018-0375-z
26
Salvatore Corrao, Giuseppe Natoli, Christiano Argano. Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with extrahepatic form: definitive evidence from meta-analysis and trial sequential analysisEuropean Journal of Gastroenterology & Hepatology 2021; 33(1): 62 doi: 10.1097/MEG.0000000000001684
27
Jitka Starekova, Scott B. Reeder. Liver fat quantification: where do we stand?Abdominal Radiology 2020; 45(11): 3386 doi: 10.1007/s00261-020-02783-1
28
Masafumi Kuzuya, Rong Qian Shi, Madoka Yanagawa, Kazuhisa Watanabe, Satoshi Samizo, Ryota Ando. Long‐lived W erner syndrome patient autopsy report: The presence of liver cirrhosis Geriatrics & Gerontology International 2021; 21(5): 433 doi: 10.1111/ggi.14149
29
Shantan Cheemerla, Maya Balakrishnan. Global Epidemiology of Chronic Liver DiseaseClinical Liver Disease 2021; 17(5): 365 doi: 10.1002/cld.1061
30
Jaskamal Padda, Khizer Khalid, Anwar Khedr, Fahriba Tasnim, Ola A Al-Ewaidat, Ayden Charlene Cooper, Gutteridge Jean-Charles. Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes MellitusCureus 2021;  doi: 10.7759/cureus.17321
31
Yuwei Wu, Jinyu Wang, Xiaodong Zheng, Yongyan Chen, Mei Huang, Qiang Huang, Weihua Xiao, Haiming Wei, Zhigang Tian, Rui Sun, Cheng Sun. Establishment and Preclinical Therapy of Patient-derived Hepatocellular Carcinoma Xenograft ModelImmunology Letters 2020; 223: 33 doi: 10.1016/j.imlet.2020.04.009
32
Dajana Lichtenstein, Claudia Luckert, Jimmy Alarcan, Georges de Sousa, Michail Gioutlakis, Efrosini S. Katsanou, Parthena Konstantinidou, Kyriaki Machera, Emanuela S. Milani, Ad Peijnenburg, Roger Rahmani, Deborah Rijkers, Anastasia Spyropoulou, Marianna Stamou, Geert Stoopen, Shana J. Sturla, Bernd Wollscheid, Nathalie Zucchini-Pascal, Albert Braeuning, Alfonso Lampen. An adverse outcome pathway-based approach to assess steatotic mixture effects of hepatotoxic pesticides in vitroFood and Chemical Toxicology 2020; 139: 111283 doi: 10.1016/j.fct.2020.111283
33
Francesco Bifari, Roberto Manfrini, Michele Dei Cas, Cesare Berra, Matteo Siano, Massimo Zuin, Rita Paroni, Franco Folli. Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)Pharmacological Research 2018; 137: 219 doi: 10.1016/j.phrs.2018.09.025
34
Annah P. Baykal, Elizabeth J. Parks, Robert Shamburek, Majid M. Syed-Abdul, Shaji Chacko, Elaine Cochran, Megan Startzell, Ahmed M. Gharib, Ronald Ouwerkerk, Khaled Z. Abd-Elmoniem, Peter J. Walter, Mary Walter, Ranganath Muniyappa, Stephanie T. Chung, Rebecca J. Brown. Leptin decreases de novo lipogenesis in patients with lipodystrophyJCI Insight 2020; 5(14) doi: 10.1172/jci.insight.137180
35
Danny Orabi, Nathan A. Berger, J. Mark Brown. Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to ChemopreventionCancers 2021; 13(14): 3473 doi: 10.3390/cancers13143473
36
Ioannis I. Moustakas, Angeliki Katsarou, Aigli-Ioanna Legaki, Iryna Pyrina, Konstantinos Ntostoglou, Alkistis-Maria Papatheodoridi, Bettina Gercken, Ioannis S. Pateras, Vassilis G. Gorgoulis, Michael Koutsilieris, Triantafyllos Chavakis, Antonios Chatzigeorgiou. Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice Independently of ObesityInternational Journal of Molecular Sciences 2021; 22(7): 3446 doi: 10.3390/ijms22073446
37
Amy W Rachfal, Struan FA Grant, Stanley S Schwartz. The Diabetes Syndrome – A Collection of Conditions with Common, Interrelated Pathophysiologic MechanismsInternational Journal of General Medicine 2021; : 923 doi: 10.2147/IJGM.S305156
38
Muhammad Usman, Nabiyah Bakhtawar. Vitamin E as an Adjuvant Treatment for Non-alcoholic Fatty Liver Disease in Adults: A Systematic Review of Randomized Controlled Trials Cureus 2020;  doi: 10.7759/cureus.9018
39
Minjuan Ma, Rui Duan, Hong Zhong, Tingming Liang, Li Guo. The Crosstalk between Fat Homeostasis and Liver Regional Immunity in NAFLDJournal of Immunology Research 2019; 2019: 1 doi: 10.1155/2019/3954890
40
Somaya Albhaisi, Arun J. Sanyal. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to DatePharmaceutical Medicine 2019; 33(6): 451 doi: 10.1007/s40290-019-00305-z
41
Somaya Albhaisi, Arun Sanyal. Recent advances in understanding and managing non-alcoholic fatty liver diseaseF1000Research 2018; 7: 720 doi: 10.12688/f1000research.14421.1
42
Reem Al-Qarni, Muhammad Iqbal, Maram Al-Otaibi, Faisal Al-Saif, Assim A. Alfadda, Hisham Alkhalidi, Fahad Bamehriz, Mazen Hassanain. Validating candidate biomarkers for different stages of non-alcoholic fatty liver diseaseMedicine 2020; 99(36): e21463 doi: 10.1097/MD.0000000000021463
43
Seoung-Woo Lee, Su-Min Baek, Kyung-Ku Kang, A-Rang Lee, Tae-Un Kim, Seong-Kyoon Choi, Yoon-Seok Roh, Il-Hwa Hong, Sang-Joon Park, Tae-Hwan Kim, Kyu-Shik Jeong, Jin-Kyu Park. Vitamin C Deficiency Inhibits Nonalcoholic Fatty Liver Disease Progression through Impaired de Novo LipogenesisThe American Journal of Pathology 2021; 191(9): 1550 doi: 10.1016/j.ajpath.2021.05.020
44
Vincenzo Cuccurullo, Giuseppe Danilo Di Stasio, Giuseppe Mazzarella, Giuseppe Lucio Cascini. Microvascular Invasion in HCC: The Molecular Imaging PerspectiveContrast Media & Molecular Imaging 2018; 2018: 1 doi: 10.1155/2018/9487938
45
Lívia Pimentel de Sant'Ana, Dalila Juliana S. Ribeiro, Aline Maria Araújo Martins, Fábio Neves dos Santos, Rafael Corrêa, Raquel das Neves Almeida, Marcos Nogueira Eberlin, Corinne F. Maurice, Kelly Grace Magalhães. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese MiceFrontiers in Immunology 2020; 10 doi: 10.3389/fimmu.2019.02926
46
Joise Teixeira, Cláudio Augusto Marroni, Paula Rosales Zubiaurre, Ana Henz, Lais Faina, Lilian Kethelyn Pinheiro, Claudio Cora Mottin, Sabrina Alves Fernandes. Phase angle and non-alcoholic fatty liver disease before and after bariatric surgeryWorld Journal of Hepatology 2020; 12(11): 1004-1019 doi: 10.4254/wjh.v12.i11.1004
47
Rongjia Qi, Rong Jiang, Hanxianzhi Xiao, Ziling Wang, Siyuan He, Lu Wang, Yaping Wang. Ginsenoside Rg1 protects against d-galactose induced fatty liver disease in a mouse model via FOXO1 transcriptional factorLife Sciences 2020; 254: 117776 doi: 10.1016/j.lfs.2020.117776
48
Tasur Kumar Seen, Muntazir Sayed, Muhammad Bilal, Jonathan Vincent Reyes, Priyanka Bhandari, Vennis Lourdusamy, Ahmed Al-khazraji, Umer Syed, Yasar Sattar, Raghav Bansal. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosisWorld Journal of Gastroenterology 2021; 27(23): 3238-3248 doi: 10.3748/wjg.v27.i23.3238
49
Xian-ju Huang, Cai-jing He, Shuai Liang, Jing Wang, Jun Li, Guang-zhong Yang, Zhang Zhao. Veratrilla baillonii Franch Could Alleviate Lipid Accumulation in LO2 Cells by Regulating Oxidative, Inflammatory, and Lipid Metabolic Signaling PathwaysFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.575772
50
Michael J. Trujillo, Johnson Chen, Jonathan M. Rubin, Jing Gao. Non-invasive imaging biomarkers to assess nonalcoholic fatty liver disease: A reviewClinical Imaging 2021; 78: 22 doi: 10.1016/j.clinimag.2021.02.039
51
Naga Swetha Samji, Rajanshu Verma, Krishna Chaitanya Keri, Ashwani K. Singal, Aijaz Ahmed, Mary Rinella, David Bernstein, Manal F. Abdelmalek, Sanjaya K. Satapathy. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical ChallengesDigestive Diseases and Sciences 2019; 64(12): 3413 doi: 10.1007/s10620-019-05716-1
52
Jamie O'Hara, Alan Finnegan, Harpal Dhillon, Leonardo Ruiz-Casas, Gabriel Pedra, Bethany Franks, George Morgan, Vanessa Hebditch, Bengt Jönsson, Mzwandile Mabhala, Tatjana Reic, Ingo Van Thiel, Vlad Ratziu, Manuel Romero-Gomez, Elisabetta Bugianesi, Jörn M. Schattenberg, Quentin M. Anstee. Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN studyJHEP Reports 2020; 2(5): 100142 doi: 10.1016/j.jhepr.2020.100142
53
Seungtae On, Hyun Young Kim, Hyo Seon Kim, Jeongwoo Park, Keon Wook Kang. Involvement of G-Protein-Coupled Receptor 40 in the Inhibitory Effects of Docosahexaenoic Acid on SREBP1-Mediated Lipogenic Enzyme Expression in Primary HepatocytesInternational Journal of Molecular Sciences 2019; 20(11): 2625 doi: 10.3390/ijms20112625
54
Waqas B. Khalid, Xucai Chen, Kang Kim. Multifocus Thermal Strain Imaging Using a Curved Linear Array Transducer for Identification of Lipids in Deep TissueUltrasound in Medicine & Biology 2021; 47(7): 1711 doi: 10.1016/j.ultrasmedbio.2021.03.005
55
Peter M. Graffy, Veit Sandfort, Ronald M. Summers, Perry J. Pickhardt. Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis AssessmentRadiology 2019; 293(2): 334 doi: 10.1148/radiol.2019190512
56
Sang Joon An, Eun-Jung Yang, Subin Oh, Kyong Jin Park, Taehyen Kim, Yeon-pyo Hong, Yun-Jung Yang. The association between urinary bisphenol A levels and nonalcoholic fatty liver disease in Korean adults: Korean National Environmental Health Survey (KoNEHS) 2015-2017Environmental Health and Preventive Medicine 2021; 26(1) doi: 10.1186/s12199-021-01010-7
57
Atsuhiro Nagasaki, Shinnichi Sakamoto, Toshiki Arai, Minami Kato, Eri Ishida, Hisako Furusho, Makiko Fujii, Takashi Takata, Mutsumi Miyauchi. Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH Journal of Clinical Periodontology 2021; 48(10): 1367 doi: 10.1111/jcpe.13523
58
Manca Povsic, On Yee Wong, Richard Perry, Juliana Bottomley. A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH)Advances in Therapy 2019; 36(7): 1574 doi: 10.1007/s12325-019-00960-3
59
Felipe David Mendonça Chaim, Lívia Bitencourt Pascoal, Fábio Henrique Mendonça Chaim, Bruna Biazon Palma, Tiago Andrade Damázio, Larissa Bastos Eloy da Costa, Rita Carvalho, Everton Cazzo, Martinho Antônio Gestic, Murillo Pimentel Utrini, Marciane Milanski, Elinton Adami Chaim, Raquel Franco Leal. Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort studyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65556-2
60
Lauren S. Strathearn, Afanasii I. Stepanov, Joan Font-Burgada. Inflammation in Primary and Metastatic Liver Tumorigenesis–Under the Influence of Alcohol and High-Fat DietsNutrients 2020; 12(4): 933 doi: 10.3390/nu12040933
61
Yeonsoo Jang, Ji Yea Lee, Seung Up Kim, Beomkyung Kim. A qualitative study of self‐management experiences in people with non‐alcoholic fatty liver diseaseNursing Open 2021;  doi: 10.1002/nop2.1025
62
Jose Hernandez Roman, Samarth Patel. Why Do Lifestyle Recommendations Fail in Most Patients with Nonalcoholic Fatty Liver Disease?Gastroenterology Clinics of North America 2020; 49(1): 95 doi: 10.1016/j.gtc.2019.10.001
63
Pang-Yen Liu, Yu-Kai Lin, Kai-Wen Chen, Kun-Zhe Tsai, Yen-Po Lin, Eiki Takimoto, Gen-Min Lin. Association of Liver Transaminase Levels and Long-Term Blood Pressure Variability in Military Young Males: The CHIEF StudyInternational Journal of Environmental Research and Public Health 2020; 17(17): 6094 doi: 10.3390/ijerph17176094
64
Hyun Ho Jo, Changwook Min, Dae-Sung Kyoung, Min-Ae Park, Sang Gyune Kim, Young Seok Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Baek Gyu Jun, Young Don Kim, Gab Jin Cheon, Jeong-Ju Yoo, Chun Chieh Yeh. Adverse outcomes after surgeries in patients with liver cirrhosis among Korean population: A population-based studyPLOS ONE 2021; 16(6): e0253165 doi: 10.1371/journal.pone.0253165
65
Andrea Gonzalez, Mayalen Valero-Breton, Camila Huerta-Salgado, Oscar Achiardi, Felipe Simon, Claudio Cabello-Verrugio. Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysisEuropean Journal of Translational Myology 2021;  doi: 10.4081/ejtm.2021.9630
66
Emilie S. Zoltick, Stephanie A. Smith-Warner, Chen Yuan, Molin Wang, Charles S. Fuchs, Jeffrey A. Meyerhardt, Andrew T. Chan, Kimmie Ng, Shuji Ogino, Meir J. Stampfer, Edward L. Giovannucci, Kana Wu. Sugar-sweetened beverage, artificially sweetened beverage and sugar intake and colorectal cancer survivalBritish Journal of Cancer 2021;  doi: 10.1038/s41416-021-01487-7
67
Eric M Sieloff, Brian Rutledge, Cuyler Huffman, Duncan Vos, Thomas Melgar. National trends and outcomes of genetically inherited non-alcoholic chronic liver disease in the USA: estimates from the National Inpatient Sample (NIS) databaseGastroenterology Report 2021; 9(1): 38 doi: 10.1093/gastro/goaa091
68
Takahiro Iwasaki, Akiko Hirose, Tetsuji Azuma, Tamie Ohashi, Kazutoshi Watanabe, Akihiro Obora, Fumiko Deguchi, Takao Kojima, Atsunori Isozaki, Takaaki Tomofuji. Correlation between ultrasound-diagnosed non-alcoholic fatty liver and periodontal condition in a cross-sectional study in JapanScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-25857-z
69
Hira Hanif, Muzammil M. Khan, Mukarram J. Ali, Pir A. Shah, Jinendra Satiya, Daryl T.Y. Lau, Aysha Aslam. A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis BMicroorganisms 2020; 8(10): 1526 doi: 10.3390/microorganisms8101526
70
Yunjung Choi, Chang Hun Lee, In Hee Kim, Eun Hae Park, SoJeong Park, Wan-Hee Yoo. Methotrexate use does not increase the prevalence of hepatic steatosis: a real-world retrospective nested case-control studyClinical Rheumatology 2021; 40(5): 2037 doi: 10.1007/s10067-020-05456-y
71
Liming Liu, Ying Zhou, Dan Dai, Hongmei Xia, Kang Zhao, Jianjun Zhang, Samuel Martins Silvestre. Antifibrotic Effects of Kangxian Ruangan Capsule on Rats with Nonalcoholic Fatty Liver Fibrosis and Hepatic Stellate Cells through Regulation of TGF-β and TLR4 Signaling PathwaysEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5649575
72
Qin Liu, Chun-Yan Niu. From “two hit theory” to “multiple hit theory”: Implications of evolution of pathogenesis concepts for treatment of non-alcoholic fatty liver diseaseWorld Chinese Journal of Digestology 2019; 27(19): 1171 doi: 10.11569/wcjd.v27.i19.1171
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
73
Rebeca Escutia-Gutiérrez, J. Samael Rodríguez-Sanabria, C. Alejandra Monraz-Méndez, Jesús García-Bañuelos, Arturo Santos-García, Ana Sandoval-Rodríguez, Juan Armendáriz-Borunda. Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASHScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91187-2
74
John C. Parker, Andreas G. Moraitis, Joseph K. Belanoff. BIOCHEMICAL AND RADIOLOGICAL CHANGES IN LIVER STEATOSIS FOLLOWING MIFEPRISTONE TREATMENT IN PATIENTS WITH HYPERCORTISOLISMAACE Clinical Case Reports 2021;  doi: 10.1016/j.aace.2021.07.001
75
Mina Karimi, Behnaz Abiri, Paul C. Guest, Mohammadreza Vafa. Physical Exercise and Natural and Synthetic Products in Health and DiseaseMethods in Molecular Biology 2022; 2343: 19 doi: 10.1007/978-1-0716-1558-4_2
76
Maja Szymanska, Daanyaal Mahmood, Timothy E. Yap, Maria F. Cordeiro. Recent Advancements in the Medical Treatment of Diabetic Retinal DiseaseInternational Journal of Molecular Sciences 2021; 22(17): 9441 doi: 10.3390/ijms22179441
77
Ling-Yan Yu, Wei-Ying Li, Jia Lin. Juglanin improves lipid metabolism disorder, liver injury, and intestinal integrity in nonalcoholic fatty liver miceWorld Chinese Journal of Digestology 2020; 28(4): 113 doi: 10.11569/wcjd.v28.i4.113
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
78
Kun Lian, Yu‐Nan Feng, Rong Li, Hao‐Lin Liu, Peng Han, Lei Zhou, Cheng‐Xiang Li, Qin Wang. Middle‐ and high‐molecular weight adiponectin levels in relation to nonalcoholic fatty liver diseaseJournal of Clinical Laboratory Analysis 2020; 34(4) doi: 10.1002/jcla.23148
79
Zhe Jiang, Takuya Hayashi, Kentaro Kashima, Kayo Kurotani, Bungo Shirouchi, Tetsuya Mizoue, Masao Sato. Alteration of Serum Phospholipid n‐6 Polyunsaturated Fatty Acid Compositions inNonalcoholicFatty Liver Disease in the Japanese Population: A Cross‐Sectional StudyLipids 2020; 55(6): 599 doi: 10.1002/lipd.12251
80
Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and TreatmentFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.615978
81
Daryl Ramai, Waqqas Tai, Michelle Rivera, Antonio Facciorusso, Nicola Tartaglia, Mario Pacilli, Antonio Ambrosi, Christian Cotsoglou, Rodolfo Sacco. Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular CarcinomaBiomedicines 2021; 9(2): 184 doi: 10.3390/biomedicines9020184
82
Roberta Forlano, Benjamin H. Mullish, Rooshi Nathwani , Ameet Dhar, Mark R. Thursz, Pinelopi Manousou . Non-Alcoholic Fatty Liver Disease and Vascular DiseaseCurrent Vascular Pharmacology 2020; 19(3): 269 doi: 10.2174/1570161118666200318103001
83
David M. Rodrigues, Arjun Kundra, Lawrence Hookey, Steven Montague. Does Point-of-Care Ultrasound Change the Needle Insertion Location During Routine Bedside Paracentesis?Journal of General Internal Medicine 2021;  doi: 10.1007/s11606-021-07042-7
84
Antonio De Vincentis, Zahra Rahmani, Moises Muley, Umberto Vespasiani-Gentilucci, Sergio Ruggiero, Parvin Zamani, Tannaz Jamialahmadi, Amirhossein Sahebkar. Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatmentDrug Discovery Today 2020; 25(7): 1277 doi: 10.1016/j.drudis.2020.05.009
85
Yinhua Ni, Yufeng Zhao, Lingyan Ma, Zhe Wang, Liyang Ni, Luting Hu, Zhengwei Fu. Pharmacological activation of REV-ERBα improves nonalcoholic steatohepatitis by regulating intestinal permeabilityMetabolism 2021; 114: 154409 doi: 10.1016/j.metabol.2020.154409
86
Khara Lucius. Nutritional and Botanical Approaches for Nonalcoholic Fatty Liver DiseaseAlternative and Complementary Therapies 2020; 26(6): 246 doi: 10.1089/act.2020.29303.klu
87
Hideo Ohuchi. What are the mechanisms for FALD and how can we prevent the progression?International Journal of Cardiology 2018; 273: 121 doi: 10.1016/j.ijcard.2018.09.071
88
Ahmed Hashem, Yogesh Shastri, Malfi Al Otaibi, Elwin Buchel, Hussam Saleh, Reyaz Ahmad, Hamouda Ahmed, Fateh Al Idris, Saleh Ahmed, Mohamed Guda, Anton Gillessen. Expert Opinion on the Management of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Middle East with a Focus on the Use of SilymarinGastroenterology Insights 2021; 12(2): 155 doi: 10.3390/gastroent12020014
89
Stefania Di Mauro, Alessandra Scamporrino, Salvatore Petta, Francesca Urbano, Agnese Filippello, Marco Ragusa, Maria T. Di Martino, Francesca Scionti, Stefania Grimaudo, Rosaria M. Pipitone, Graziella Privitera, Antonino Di Pino, Roberto Scicali, Luca Valenti, Paola Dongiovanni, Anna Fracanzani, Agata M. Rabuazzo, Antonio Craxì, Michele Purrello, Francesco Purrello, Salvatore Piro. Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severityLiver International 2019; 39(9): 1742 doi: 10.1111/liv.14167
90
Valentina A. Zavala, Paige M. Bracci, John M. Carethers, Luis Carvajal-Carmona, Nicole B. Coggins, Marcia R. Cruz-Correa, Melissa Davis, Adam J. de Smith, Julie Dutil, Jane C. Figueiredo, Rena Fox, Kristi D. Graves, Scarlett Lin Gomez, Andrea Llera, Susan L. Neuhausen, Lisa Newman, Tung Nguyen, Julie R. Palmer, Nynikka R. Palmer, Eliseo J. Pérez-Stable, Sorbarikor Piawah, Erik J. Rodriquez, María Carolina Sanabria-Salas, Stephanie L. Schmit, Silvia J. Serrano-Gomez, Mariana C. Stern, Jeffrey Weitzel, Jun J. Yang, Jovanny Zabaleta, Elad Ziv, Laura Fejerman. Cancer health disparities in racial/ethnic minorities in the United StatesBritish Journal of Cancer 2021; 124(2): 315 doi: 10.1038/s41416-020-01038-6
91
Isabel Molwitz, Miriam Leiderer, Cansu Özden, Jin Yamamura. Dual-Energy Computed Tomography for Fat Quantification in the Liver and Bone Marrow: A Literature ReviewRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 2020; 192(12): 1137 doi: 10.1055/a-1212-6017
92
Steffen Landerer, Sandra Kalthoff, Stefan Paulusch, Christian P. Strassburg. A Gilbert syndrome-associated haplotype protects against fatty liver disease in humanized transgenic miceScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65481-4
93
Timothy M.E. Davis, Kirsten E. Peters, S. A. Paul Chubb, Leon A. Adams, Gary P. Jeffrey, Wendy A. Davis. Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes StudyJournal of Clinical Medicine 2020; 9(11): 3409 doi: 10.3390/jcm9113409
94
Yusuf Yilmaz, Christopher D. Byrne, Giovanni Musso. A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLDExpert Review of Gastroenterology & Hepatology 2021; 15(4): 345 doi: 10.1080/17474124.2021.1860019
95
Khalid Alswat, Faisal M Sanai, Waleed Al-hamoudi, Mona Ismail, Yaser Dahlan, Hamdan Saleh AlGhamdi, Ibrahim Altraif, Abduljaleel Alalwan, Mohamed MA Babatin, Saleh A Alqahtani. Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) RegistryDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 1167 doi: 10.2147/DMSO.S300051
96
Cheng Fang, Paul S. Sidhu. Ultrasound-based liver elastography: current results and future perspectivesAbdominal Radiology 2020; 45(11): 3463 doi: 10.1007/s00261-020-02717-x
97
Yu-Cheng Lin, Chi-Chien Wu, Yen-Hsuan Ni. New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver DiseaseFrontiers in Pediatrics 2020; 8 doi: 10.3389/fped.2020.603654
98
Minjie Lin, Jungke Long, Wenbo Li, Chenxuan Yang, Patricia Loughran, Robert O’Doherty, Timothy R. Billiar, Meihong Deng, Melanie J. Scott. Hepatocyte high-mobility group box 1 protects against steatosis and cellular stress during high fat diet feedingMolecular Medicine 2020; 26(1) doi: 10.1186/s10020-020-00227-6
99
Teresa Vanessa Fiorentino, Elena Succurro, Angela Sciacqua, Francesco Andreozzi, Francesco Perticone, Giorgio Sesti. Non‐alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose toleranceDiabetes/Metabolism Research and Reviews 2020; 36(8) doi: 10.1002/dmrr.3333
100
Stefan Chiriac, Carol Stanciu, Irina Girleanu, Camelia Cojocariu, Catalin Sfarti, Ana-Maria Singeap, Tudor Cuciureanu, Laura Huiban, Cristina Maria Muzica, Sebastian Zenovia, Robert Nastasa, Anca Trifan, Branka Filipović. Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the MatterCanadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6696857
101
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventionsLife Sciences 2021; 271: 119220 doi: 10.1016/j.lfs.2021.119220
102
Jiayun M. Fang, Jerome Cheng, Michael F. Chang, Joseph Ahn, Maria Westerhoff. Transient elastography versus liver biopsy: discordance in evaluations for fibrosis and steatosis from a pathology standpointModern Pathology 2021; 34(10): 1955 doi: 10.1038/s41379-021-00851-5
103
Qiaoling Wang, Binxia Chang, Xiaoyan Li, Zhengsheng Zou. Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease PathogenesisJournal of Clinical and Translational Hepatology 2021; 0(000): 1 doi: 10.14218/JCTH.2020.00104
104
Nina L. Gluchowski, Katlyn R. Gabriel, Chandramohan Chitraju, Roderick T. Bronson, Niklas Mejhert, Sebastian Boland, Kun Wang, Zon Weng Lai, Robert V. Farese, Tobias C. Walther. Hepatocyte Deletion of Triglyceride‐Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in MiceHepatology 2019; 70(6): 1972 doi: 10.1002/hep.30765
105
Nikta Afzali, Seyed Shayan Ebadi, Hasan Afzali, Mohammad Reza Sharif, Mahdi Vazirian, Seyed Alireza Ebadi, Vahid Shahkarami, Habibollah Rahimi. Effect of Beta vulgaris Extract on Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical TrialHepatitis Monthly 2020; 20(7) doi: 10.5812/hepatmon.102125
106
Dandan Song, Chengqian Li, Zhongchao Wang, Yuhang Zhao, Baoming Shen, Wenjuan Zhao. Association of non‐alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: A meta‐analysis of observational studiesJournal of Diabetes Investigation 2021; 12(8): 1471 doi: 10.1111/jdi.13489
107
Meng Zhang, Li Li, Jing Chen, Bei Li, Yutao Zhan, Chuan Zhang. Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver diseaseMedicine 2019; 98(18): e15362 doi: 10.1097/MD.0000000000015362
108
Liu Li, Li Yang, Feng Yang, Xin-lan Zhao, Shengjiang Xue, Fang-hua Gong. Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed MiceJournal of Inflammation Research 2021; : 1959 doi: 10.2147/JIR.S302934
109
Leslimar Rios-Colon, Elena Arthur, Suryakant Niture, Qi Qi, John T. Moore, Deepak Kumar. The Role of Exosomes in the Crosstalk between Adipocytes and Liver Cancer CellsCells 2020; 9(9): 1988 doi: 10.3390/cells9091988
110
Ping Chen, Yusheng Li, Li Xiao. Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLRExperimental and Therapeutic Medicine 2021; 22(4) doi: 10.3892/etm.2021.10543
111
Aparamita Pandey, Prachi Dabhade, Anand Kumarasamy. Inflammatory Effects of Subacute Exposure of Roundup in Rat Liver and Adipose TissueDose-Response 2019; 17(2): 155932581984338 doi: 10.1177/1559325819843380
112
A. Tvarijonaviciute, R. Barić-Rafaj, A. Horvatic, A. Muñoz-Prieto, N. Guillemin, E. Lamy, A. Tumpa, J.J. Ceron, S. Martinez-Subiela, V. Mrljak. Identification of changes in serum analytes and possible metabolic pathways associated with canine obesity-related metabolic dysfunctionThe Veterinary Journal 2019; 244: 51 doi: 10.1016/j.tvjl.2018.12.006
113
Yvonne Huber, Jörn M Schattenberg. Prävention gastroenterologischer Tumorerkrankungen2020; : 173 doi: 10.1007/978-3-662-58879-6_10
114
Evan E. Lebovitz, Anh Vinh T. Nguyen, Tetsuro Sakai. Economic considerations in abdominal transplantationBest Practice & Research Clinical Anaesthesiology 2020; 34(1): 15 doi: 10.1016/j.bpa.2020.01.002
115
Derek J. Erstad, Allen A. Razavi, Shen Li, Kenneth K. Tanabe, Bryan C. Fuchs. Hepatocellular CarcinomaMolecular and Translational Medicine 2019; : 255 doi: 10.1007/978-3-030-21540-8_13
116
Lyssia Castellanos-Tapia, María Elizabeth Tejero-Barrera, Soraya Salas-Silva, Arturo Simoni-Nieves, Alejandro Escobedo-Calvario, Luis E. Gomez-Quiroz. Mediterranean-like mix of fatty acids induces cellular protection on lipid-overloaded hepatocytes from western diet fed miceAnnals of Hepatology 2020; 19(5): 489 doi: 10.1016/j.aohep.2020.06.005
117
Acharya Balkrishna, Vivek Gohel, Rani Singh, Monali Joshi, Yash Varshney, Jyotish Srivastava, Kunal Bhattacharya, Anurag Varshney. Tri-Herbal Medicine Divya Sarva-Kalp-Kwath (Livogrit) Regulates Fatty Acid-Induced Steatosis in Human HepG2 Cells through Inhibition of Intracellular Triglycerides and Extracellular Glycerol LevelsMolecules 2020; 25(20): 4849 doi: 10.3390/molecules25204849
118
Faisal M. Sanai, Abdullah Al Khathlan, Ahmad Al Fadhli, Ahmad S. Jazzar, Al Moutaz Hashim, Eid Mansour, Faisal Abaalkhail, Fuad Hasan, Hajer Al Mudaiheem, Huda Al Quraishi, Juliana Bottomley, Khalid A. Alswat, Mohammed Al Ghamdi, Mohamed Farghaly, Motaz Fathy, Nancy Awad, Omneya Mohamed, Sam Kozma, Waleed Al-Hamoudi, Ahmed Al-jedai. Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and KuwaitHepatology International 2021; 15(4): 912 doi: 10.1007/s12072-021-10182-x
119
Shailja C Shah, Xiangzhu Zhu, Qi Dai, Richard M Peek, Martha J Shrubsole. Magnesium intake is associated with a reduced risk of incident liver cancer, based on an analysis of the NIH-American Association of Retired Persons (NIH-AARP) Diet and Health Study prospective cohortThe American Journal of Clinical Nutrition 2021; 113(3): 630 doi: 10.1093/ajcn/nqaa326
120
Hee Jin Jeong, Song Hee Lee, Hee Eun Kang. Changes in digoxin pharmacokinetics associated with hepatic P‐glycoprotein upregulation in rats with non‐alcoholic fatty liver diseaseFundamental & Clinical Pharmacology 2021;  doi: 10.1111/fcp.12687
121
Amélio F. Godoy-Matos, Wellington S. Silva Júnior, Cynthia M. Valerio. NAFLD as a continuum: from obesity to metabolic syndrome and diabetesDiabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00570-y
122
Soumya Murag, Aijaz Ahmed, Donghee Kim. Recent Epidemiology of Nonalcoholic Fatty Liver DiseaseGut and Liver 2021; 15(2): 206 doi: 10.5009/gnl20127
123
Fatemeh Haidari, Abdollah Hojhabrimanesh, Bizhan Helli, Seyed-Saeed Seyedian, Kambiz Ahmadi-Angali. An energy-restricted high-protein diet supplemented with β-cryptoxanthin alleviated oxidative stress and inflammation in nonalcoholic fatty liver disease: a randomized controlled trialNutrition Research 2020; 73: 15 doi: 10.1016/j.nutres.2019.08.009
124
Rohit Loomba, Robert Wong, Jeremy Fraysse, Sanatan Shreay, Suying Li, Stephen Harrison, Stuart C. Gordon. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare dataAlimentary Pharmacology & Therapeutics 2020; 51(11): 1149 doi: 10.1111/apt.15679
125
Shan Dang, Jian Zhou, Zongyan Wang, Kunning Wang, Shejiao Dai, Shuixiang He. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinomaBiomedicine & Pharmacotherapy 2018; 106: 966 doi: 10.1016/j.biopha.2018.06.042
126
Lin Wei, Hui-Guo Ding. Relationship between Helicobacter pylori infection and nonalcoholic fatty liver diseaseMedicine 2021; 100(31): e26706 doi: 10.1097/MD.0000000000026706
127
Tamoore Arshad, Pegah Golabi, James Paik, Alita Mishra, Zobair M. Younossi. Prevalence of Nonalcoholic Fatty Liver Disease in the Female PopulationHepatology Communications 2019; 3(1): 74 doi: 10.1002/hep4.1285
128
Sydney Pomenti, Cassandra Gandle, Hamzah Abu Sbeih, Meaghan Phipps, Alexandra Livanos, Averill Guo, Jonathan Yeh, Heather Burney, Hao Liu, Lara Dakhoul, Carla Kettler, Samer Gawrieh, Andrew deLemos, Andrew Scanga, Naga Chalasani, Ethan Miller, Julia Wattacheril. Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States CohortHepatology Communications 2020; 4(11): 1708 doi: 10.1002/hep4.1575
129
Allyce Caines, Ranya Selim, Reena Salgia. The Changing Global Epidemiology of Hepatocellular CarcinomaClinics in Liver Disease 2020; 24(4): 535 doi: 10.1016/j.cld.2020.06.001
130
Verena C Obmann, Christina Marx, Annalisa Berzigotti, Nando Mertineit, Joris Hrycyk, Christoph Gräni, Lukas Ebner, Michael Ith, Johannes T Heverhagen, Andreas Christe, Adrian T Huber. Liver MRI susceptibility-weighted imaging (SWI) compared to T2* mapping in the presence of steatosis and fibrosisEuropean Journal of Radiology 2019; 118: 66 doi: 10.1016/j.ejrad.2019.07.001
131
Luis E. Simental-Mendía, Claudia I. Gamboa-Gómez, Fernando Guerrero-Romero, Mario Simental-Mendía, Adriana Sánchez-García, Mariana Rodríguez-Ramírez. Pharmacological Properties of Plant-Derived Natural Products and Implications for Human HealthAdvances in Experimental Medicine and Biology 2021; 1308: 257 doi: 10.1007/978-3-030-64872-5_18
132
Rebecca K. Vincent, David M. Williams, Marc Evans. A look to the future in non‐alcoholic fatty liver disease: Are glucagon‐like peptide‐1 analogues or sodium‐glucose co‐transporter‐2 inhibitors the answer?Diabetes, Obesity and Metabolism 2020; 22(12): 2227 doi: 10.1111/dom.14196
133
Lauren A. Newman, Michael J. Sorich, Andrew Rowland. Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver DiseaseJournal of Clinical Medicine 2020; 9(7): 2032 doi: 10.3390/jcm9072032
134
Ioannis Ilias, Spyridon Goulas, Lina Zabuliene. Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19World Journal of Clinical Cases 2021; 9(12): 2711-2720 doi: 10.12998/wjcc.v9.i12.2711
135
Gaurav Gupta, Ridhima Wadhwa, Parijat Pandey, Sachin Kumar Singh, Monica Gulati, Saurabh Sajita, Meenu Mehta, Avinash Kumar Singh, Harish Dureja, Trudi Collet, Kavita Pabreja, Dinesh Kumar Chellappan, Kamal Dua. Pathophysiology of Obesity-Induced Health Complications2020; : 81 doi: 10.1007/978-3-030-35358-2_5
136
Hongwei Yi, Deyi Xu, Xudong Wu, Fang Xu, Lin Lin, Huiping Zhou. Isosteviol Protects Free Fatty Acid- and High Fat Diet-Induced Hepatic InjuryviaModulating PKC-β/p66Shc/ROS and Endoplasmic Reticulum Stress PathwaysAntioxidants & Redox Signaling 2019; 30(17): 1949 doi: 10.1089/ars.2018.7521
137
Taisiia Turankova, Oleg Blyuss, Alexey Brazhnikov, Andrey Svistunov, Kurinchi Selvan Gurusamy, Chavdar S Pavlov. Transient elastography with controlled attenuation parameter (CAP) for diagnosis of moderate or severe steatosis in people with suspected non-alcoholic fatty liver diseaseCochrane Database of Systematic Reviews 2020;  doi: 10.1002/14651858.CD013670
138
Marc Evans, Angharad R. Morgan, Dipesh Patel, Ketan Dhatariya, Sharlene Greenwood, Philip Newland-Jones, Debbie Hicks, Zaheer Yousef, Jim Moore, Bethany Kelly, Sarah Davies, Umesh Dashora. Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related ComplicationsDiabetes Therapy 2021; 12(1): 87 doi: 10.1007/s13300-020-00963-2
139
Enxiang Zhang, Shutao Yin, Shuang Zhao, Chong Zhao, Mingzhu Yan, Lihong Fan, Hongbo Hu. Protective effects of glycycoumarin on liver diseasesPhytotherapy Research 2020; 34(6): 1191 doi: 10.1002/ptr.6598
140
Alexander L. Ticho, Pooja Malhotra, Pradeep K. Dudeja, Ravinder K. Gill, Waddah A. Alrefai. Comprehensive Physiology2019; : 21 doi: 10.1002/cphy.c190007
141
Antoni Sureda, Xavier Capó, Silvia Tejada. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases2021; : 83 doi: 10.1016/B978-0-12-816488-4.00007-3
142
Winston Hernández-Ceballos, Jacqueline Cordova-Gallardo, Nahum Mendez-Sanchez. Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic DiseasesJournal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00131
143
Elham Karimi-Sales, Sajad Jeddi, Mohammad Reza Alipour. trans-Chalcone inhibits transforming growth factor-β1 and connective tissue growth factor-dependent collagen expression in the heart of high-fat diet-fed ratsArchives of Physiology and Biochemistry 2020; : 1 doi: 10.1080/13813455.2020.1764045
144
Hao Chiang, Hsu-Feng Lu, Jui-Chieh Chen, Yu-Hsin Chen, Hsi-Tai Sun, Hsiu-Chen Huang, Hsiao-Hsuan Tien, Cheng Huang, Fatima Martel. Adlay Seed (Coix lacryma-jobi L.) Extracts Exhibit a Prophylactic Effect on Diet-Induced Metabolic Dysfunction and Nonalcoholic Fatty Liver Disease in MiceEvidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/9519625
145
Jing Xie, Yong Shao, Jin Liu, Meilan Cui, Xiuxiao Xiao, Jingbo Gong, Binghua Xue, Qunwei Zhang, Xianwen Hu, Haifeng Duan. K27Q/K29Q mutations in sphingosine kinase 1 attenuate high-fat diet induced obesity and altered glucose homeostasis in miceScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77096-w
146
Jarren R. Oates, Melanie C. McKell, Maria E. Moreno-Fernandez, Michelle S. M. A. Damen, George S. Deepe, Joseph E. Qualls, Senad Divanovic. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac AttackFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02893
147
Xuan G. Luong, Sarah K. Stevens, Andreas Jekle, Tse-I Lin, Kusum Gupta, Dinah Misner, Sushmita Chanda, Sucheta Mukherjee, Caroline Williams, Antitsa Stoycheva, Lawrence M. Blatt, Leonid N. Beigelman, Julian A. Symons, Pierre Raboisson, David McGowan, Koen Vandyck, Jerome Deval, Olivier Barbier. Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)PLOS ONE 2020; 15(12): e0240338 doi: 10.1371/journal.pone.0240338
148
Cayden Beyer, Chloe Hutton, Anneli Andersson, Kento Imajo, Atsushi Nakajima, Dustin Kiker, Rajarshi Banerjee, Andrea Dennis, Wan-Long Chuang. Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohortPLOS ONE 2021; 16(4): e0249491 doi: 10.1371/journal.pone.0249491
149
Associated Liver Disease in Alcoholic Chronic PancreatitisAcademia Journal of Surgery 2020; 3(1): 172 doi: 10.47008/ajs/2020.3.1.37
150
Si-Qin Long, Xiu-Feng Yu, Yu-Li Ge, Lu-Xiang Liu. Ginkgolide B ameliorates high-fat diet-induced hepatic steatosis and inflammation in miceWorld Chinese Journal of Digestology 2020; 28(13): 519 doi: 10.11569/wcjd.v28.i13.519
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
151
Joseph M. Salamoun, Christopher J. Garcia, Stefan R. Hargett, Jacob H. Murray, Sing-Young Chen, Martina Beretta, Stephanie J. Alexopoulos, Divya P. Shah, Ellen M. Olzomer, Simon P. Tucker, Kyle L. Hoehn, Webster L. Santos. 6-Amino[1,2,5]oxadiazolo[3,4-b]pyrazin-5-ol Derivatives as Efficacious Mitochondrial Uncouplers in STAM Mouse Model of Nonalcoholic SteatohepatitisJournal of Medicinal Chemistry 2020; 63(11): 6203 doi: 10.1021/acs.jmedchem.0c00542
152
Yang Zou, Ling Zhong, Chong Hu, Mingchun Zhong, Nan Peng, Guotai Sheng. LDL/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort studyLipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01457-1
153
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease researchWorld Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
154
Claudia Luckert, Albert Braeuning, Georges de Sousa, Sigrid Durinck, Efrosini S. Katsanou, Parthena Konstantinidou, Kyriaki Machera, Emanuela S. Milani, Ad A. C. M. Peijnenburg, Roger Rahmani, Andreja Rajkovic, Deborah Rijkers, Anastasia Spyropoulou, Marianna Stamou, Geert Stoopen, Shana Sturla, Bernd Wollscheid, Nathalie Zucchini-Pascal, Alfonso Lampen. Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with CyproconazoleChemical Research in Toxicology 2018; 31(8): 784 doi: 10.1021/acs.chemrestox.8b00112
155
Ioan Sporea, Ruxandra Mare, Alina Popescu, Silviu Nistorescu, Victor Baldea, Roxana Sirli, Adina Braha, Alexandra Sima, Romulus Timar, Raluca Lupusoru. Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life ExperienceJournal of Clinical Medicine 2020; 9(4): 1032 doi: 10.3390/jcm9041032
156
Manca Povsic, Louisa Oliver, Neha Raju Jiandani, Richard Perry, Juliana Bottomley. A structured literature review of interventions used in the management of nonalcoholic steatohepatitis ( NASH ) Pharmacology Research & Perspectives 2019; 7(3): e00485 doi: 10.1002/prp2.485
157
Joseph Pierre Aboumsallem, Ilayaraja Muthuramu, Mudit Mishra, Bart De Geest. Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic MiceInternational Journal of Molecular Sciences 2019; 20(9): 2222 doi: 10.3390/ijms20092222
158
Andrea Gonzalez, Camila Huerta-Salgado, Josué Orozco-Aguilar, Francisco Aguirre, Franco Tacchi, Felipe Simon, Claudio Cabello-Verrugio, Ana Cipak Gasparovic. Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD)Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/1617805
159
Jiang-Hua Zhou, Jing-Jing Cai, Zhi-Gang She, Hong-Liang Li. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practiceWorld Journal of Gastroenterology 2019; 25(11): 1307-1326 doi: 10.3748/wjg.v25.i11.1307
160
Victoria L. Slaughter, John W. Rumsey, Rachel Boone, Duaa Malik, Yunqing Cai, Narasimhan Narasimhan Sriram, Christopher J. Long, Christopher W. McAleer, Stephen Lambert, Michael L. Shuler, J. J. Hickman. Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluationScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92264-2
161
Ciniso Sylvester Shabangu, Jee-Fu Huang, Hui-Hua Hsiao, Ming-Lung Yu, Wan-Long Chuang, Shu-Chi Wang. Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver DiseasesInternational Journal of Molecular Sciences 2020; 21(10): 3732 doi: 10.3390/ijms21103732
162
Eréndira Villanueva-Ortega, Lucia A. Méndez-García, Guadalupe N. Garibay-Nieto, Estibalitz Laresgoiti-Servitje, Patricia Medina-Bravo, Alfonso Olivos-García, Martín H. Muñoz-Ortega, Javier Ventura-Juárez, Galileo Escobedo. Growth hormone ameliorates high glucose-induced steatosis on in vitro cultured human HepG2 hepatocytes by inhibiting de novo lipogenesis via ChREBP and FAS suppressionGrowth Hormone & IGF Research 2020; : 101332 doi: 10.1016/j.ghir.2020.101332
163
Asim Kichloo, Shantanu Solanki, Khwaja F Haq, Dushyant Dahiya, Beth Bailey, Dhanshree Solanki, Jagmeet Singh, Michael Albosta, Farah Wani, Michael Aljadah, Harshil Shah, Hafiz Khan, Syed-Mohammed Jafri. Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient populationWorld Journal of Gastrointestinal Pathophysiology 2021; 12(2): 14-24 doi: 10.4291/wjgp.v12.i2.14
164
Banrida Wahlang, Savitri Appana, K. Cameron Falkner, Craig J. McClain, Guy Brock, Matthew C. Cave. Insecticide and metal exposures are associated with a surrogate biomarker for non-alcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003–2004Environmental Science and Pollution Research 2020; 27(6): 6476 doi: 10.1007/s11356-019-07066-x
165
Alexandra Zaborowski, Helen M. Heneghan, Barbara Fiore, Anthony Stafford, Tom Gallagher, Justin Geoghegan, Donal Maguire, Emir Hoti. Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma: The Irish Experience of the Mayo ProtocolTransplantation 2020; 104(10): 2097 doi: 10.1097/TP.0000000000003114
166
Gen Yamada, Yasuhiro Hagiwara, Takeshi Kimura, Yoshinori Takeuchi, Koji Oba, Katsunori Masuda, Yutaka Matsuyama. Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese IndividualsAmerican Journal of Gastroenterology 2021; 116(4): 733 doi: 10.14309/ajg.0000000000001030
167
Christian S. Alvarez, Barry I. Graubard, Jake E. Thistle, Jessica L. Petrick, Katherine A. McGlynn. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow‐upHepatology 2020; 72(2): 430 doi: 10.1002/hep.31040
168
Florence Wong, K. Rajender Reddy, Jacqueline G. O’Leary, Guadalupe Garcia‐Tsao, Patrick S. Kamath, Jasmohan S. Bajaj. ReplyLiver Transplantation 2019; 25(10): 1586 doi: 10.1002/lt.25612
169
Hideki Fujii, Haruna Doi, Tetsuhisa Ko, Taito Fukuma, Toru Kadono, Kohei Asaeda, Reo Kobayashi, Takahiro Nakano, Toshifumi Doi, Yoshikazu Nakatsugawa, Shinya Yamada, Takeshi Nishimura, Naoya Tomatsuri, Hideki Sato, Yusuke Okuyama, Hiroyuki Kimura, Etsuko Kishimoto, Nami Nakabe, Takatomo Shima. Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort studyBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01369-x
170
Victor Sánchez, Annette Brandt, Cheng Jun Jin, Dragana Rajcic, Anna Janina Engstler, Finn Jung, Anika Nier, Anja Baumann, Ina Bergheim. Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose IntoleranceNutrients 2021; 13(3): 959 doi: 10.3390/nu13030959
171
Scott A. Reisman, Deborah A. Ferguson, Chun‐Yue I. Lee, Joel W. Proksch. Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitisJournal of Biochemical and Molecular Toxicology 2020; 34(9) doi: 10.1002/jbt.22526
172
Jana Hudcova, Syed Talha Qasmi, Robin Ruthazer, Ahsan Waqas, Syed Basit Haider, Roman Schumann. Early Allograft Dysfunction Following Liver Transplant: Impact of Obesity, Diabetes, and Red Blood Cell TransfusionTransplantation Proceedings 2021; 53(1): 119 doi: 10.1016/j.transproceed.2020.02.168
173
Magdy El-Gohary, Mike Moore, Paul Roderick, Emily Watkins, Joanne Dash, Tina Reinson, Colin Newell, Miranda Kim, Beth Stuart, Taeko Becque, Nick Sheron, Isabelle Chemin. Local care and treatment of liver disease (LOCATE) – A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary carePLOS ONE 2018; 13(12): e0208798 doi: 10.1371/journal.pone.0208798
174
Nilay D. Solanki, Kirti Vadi, Sandip Patel. Alleviating effect of Ficus racemosa in high-fat-high-fructose diet-induced non-alcoholic fatty liver diseaseIndian Journal of Physiology and Pharmacology 2021; 65: 12 doi: 10.25259/IJPP_406_2020
175
Timothy M.E. Davis. Diabetes and metabolic dysfunction-associated fatty liver diseaseMetabolism 2021; 123: 154868 doi: 10.1016/j.metabol.2021.154868
176
Andrea C. Postmus, Ines Sturmlechner, Johan W. Jonker, Jan M. van Deursen, Bart van de Sluis, Janine K. Kruit. Senescent cells in the development of cardiometabolic diseaseCurrent Opinion in Lipidology 2019; 30(3): 177 doi: 10.1097/MOL.0000000000000602
177
Sangmin You, Ai-Min Cui, Syed F. Hashmi, Xinmu Zhang, Christina Nadolny, Yuan Chen, Qiwen Chen, Xin Bush, Zachary Hurd, Winifer Ali, Gang Qin, Ruitang Deng. Dysregulation of bile acids increases the risk for preterm birth in pregnant womenNature Communications 2020; 11(1) doi: 10.1038/s41467-020-15923-4
178
Yongjia Li, Xinming Su, Nidhi Rohatgi, Yan Zhang, Jonathan R. Brestoff, Kooresh I. Shoghi, Yalin Xu, Clay F. Semenkovich, Charles A. Harris, Lindsay L. Peterson, Katherine N. Weibaecher, Steven L. Teitelbaum, Wei Zou. Hepatic lipids promote liver metastasisJCI Insight 2020; 5(17) doi: 10.1172/jci.insight.136215
179
Keyang Xu, Xu Zhao, Xiaoqing Fu, Kechen Xu, Zhaoyi Li, Liangbin Miao, Yan Li, Zhaobin Cai, Liang Qiao, Jianfeng Bao. Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic studyBiomedicine & Pharmacotherapy 2019; 117: 109158 doi: 10.1016/j.biopha.2019.109158
180
N. M. Delzenne, C. Knudsen, M. Beaumont, J. Rodriguez, A. M. Neyrinck, L. B. Bindels. Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut–liver axisProceedings of the Nutrition Society 2019; 78(3): 319 doi: 10.1017/S0029665118002756
181
Guotai Sheng, Nan Peng, Chong Hu, Ling Zhong, Mingchun Zhong, Yang Zou. The albumin-to-alkaline phosphatase ratio as an independent predictor of future non-alcoholic fatty liver disease in a 5-year longitudinal cohort study of a non-obese Chinese populationLipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01479-9
182
Reza Etminani, ZaharaAbdul Manaf, Suzana Shahar, Leila Azadbakht, Peyman Adibi. Predictors of nonalcoholic fatty liver disease among middle-aged IraniansInternational Journal of Preventive Medicine 2020; 11(1): 113 doi: 10.4103/ijpvm.IJPVM_274_19
183
Olfa Khalifa, Khaoula Errafii, Nayla S. Al-Akl, Abdelilah Arredouani. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis BiomarkersDisease Markers 2020; 2020: 1 doi: 10.1155/2020/8822859
184
Toshihiro Sakai, Hiroyuki Ohba, Shingo Nishiyama, Takeharu Kakiuchi, Osamu Inoue, Hideo Tsukada. Sensitive and early detection of mitochondrial dysfunction in the liver of NASH model mice by PET imaging with 18F-BCPP-BFEJNMMI Research 2018; 8(1) doi: 10.1186/s13550-018-0420-6
185
Konstantinos Damiris, Zaid H Tafesh, Nikolaos Pyrsopoulos. Efficacy and safety of anti-hepatic fibrosis drugsWorld Journal of Gastroenterology 2020; 26(41): 6304-6321 doi: 10.3748/wjg.v26.i41.6304
186
Kristin M Hirahatake, Richard S Bruno, Bradley W Bolling, Christopher Blesso, Lacy M Alexander, Sean H Adams. Dairy Foods and Dairy Fats: New Perspectives on Pathways Implicated in Cardiometabolic HealthAdvances in Nutrition 2019;  doi: 10.1093/advances/nmz105
187
Fan Yang, Ping Huang, Liandong Shi, Feng Liu, Aimei Tang, Shaohui Xu. <p>Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice</p>Drug Design, Development and Therapy 2020; : 3865 doi: 10.2147/DDDT.S258857
188
T. V. Fiorentino, S. Miceli, E. Succurro, A. Sciacqua, F. Andreozzi, G. Sesti. Nonalcoholic fatty liver disease is associated with a decreased myocardial mechano‐energetic efficiencyJournal of Internal Medicine 2021; 289(2): 221 doi: 10.1111/joim.13155
189
Christian L. Horn, Anvi C. Ta, Nadege T. Gunn. Current and Emerging Treatments for Non-alcoholic SteatohepatitisCurrent Hepatology Reports 2020; 19(4): 391 doi: 10.1007/s11901-020-00540-y
190
Zobair M. Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic SteatohepatitisClinical Gastroenterology and Hepatology 2019; 17(10): 2093 doi: 10.1016/j.cgh.2019.01.001
191
Caterina Formichi, Laura Nigi, Giuseppina Emanuela Grieco, Carla Maccora, Daniela Fignani, Noemi Brusco, Giada Licata, Guido Sebastiani, Francesco Dotta. Non-Coding RNAs: Novel Players in Insulin Resistance and Related DiseasesInternational Journal of Molecular Sciences 2021; 22(14): 7716 doi: 10.3390/ijms22147716
192
Sathiyamoorthy Selladurai, Abhilash Verma, Arun K. Thittai. Toward Quantitative and Operator-independent Quasi-static Ultrasound Elastography: An Ex Vivo Feasibility StudyUltrasonic Imaging 2020; 42(4-5): 179 doi: 10.1177/0161734620921532
193
Long Le, Ravina Kullar, Hussein M. Saleh, Sammy Saab. Preferred Noninvasive Testing for Nonalcoholic SteatohepatitisDigestive Diseases and Sciences 2020; 65(12): 3719 doi: 10.1007/s10620-020-06382-4
194
Ke Xu, Mingming Shi, Weiteng Zhang, Yiyi Shi, Qiantong Dong, Xian Shen, Xiaolei Chen, Ji Lin. Preoperative Fibrosis-4 (FIB-4) Evaluation May Be Helpful to Evaluate Prognosis of Gastric Cancer Patients Undergoing Operation: A Retrospective StudyFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.655343
195
Chiranjeevi Gadiparthi, Moshe Spatz, Simi Greenberg, Umair Iqbal, Sowjanya Kanna, Sanjaya K Satapathy, Arkady Broder, Aijaz Ahmed. NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United StatesJournal of Clinical and Translational Hepatology 2020; 8(2): 215 doi: 10.14218/JCTH.2020.00014
196
Manuel Romero-Gomez, Nandita Kachru, Meritxell Ascanio Zamorano, Josep Darba, Sanatan Shreay. Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in SpainMedicine 2020; 99(50): e23506 doi: 10.1097/MD.0000000000023506
197
Seth A. Waits, Kyle H. Sheetz, Amir A. Ghaferi. Considering Bariatric Surgery in Patients With Nonalcoholic Steatohepatitis—Worth the RiskJAMA Network Open 2019; 2(2): e190053 doi: 10.1001/jamanetworkopen.2019.0053
198
Bertha Marin-Alejandre, Itziar Abete, Irene Cantero, Jose Riezu-Boj, Fermín Milagro, J. Monreal, Mariana Elorz, José Herrero, Alberto Benito-Boillos, Jorge Quiroga, Ana Martinez-Echeverria, Juan Uriz-Otano, María Huarte-Muniesa, Josep Tur, J. Martínez, M. Zulet. Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy ControlsNutrients 2019; 11(2): 322 doi: 10.3390/nu11020322
199
Fabian Seebacher, Anja Zeigerer, Nora Kory, Natalie Krahmer. Hepatic lipid droplet homeostasis and fatty liver diseaseSeminars in Cell & Developmental Biology 2020; 108: 72 doi: 10.1016/j.semcdb.2020.04.011
200
Anchalia Chandrakumaran, Mohammad Shadab Siddiqui. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver TransplantGastroenterology Clinics of North America 2020; 49(1): 165 doi: 10.1016/j.gtc.2019.09.005
201
Chanh-Phong Tran, John J Kim, Jordan J Feld, William WL Wong. Cost-effectiveness of obeticholic acid for the treatment of non-alcoholic steatohepatitis: an early economic evaluationCanadian Liver Journal 2021; : e20210011 doi: 10.3138/canlivj-2021-0011
202
Rishi Rikhi, Tavankit Singh, Jamak Modaresi Esfeh. Work up of fatty liver by primary care physicians, reviewAnnals of Medicine and Surgery 2020; 50: 41 doi: 10.1016/j.amsu.2020.01.001
203
Haider Ghazanfar, Sameer D Kandhi, Iqra Nawaz, Nismat Javed, Minu C Abraham , Mohamed Farag, Jaydeep Mahasamudram, Vishwa B Patel, Faryal Altaf, Harish Patel. Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Non-Alcoholic Steatohepatitis: A Clinical Review ArticleCureus 2021;  doi: 10.7759/cureus.15141
204
Ali Canbay, Nandita Kachru, Jennifer Scarlet Haas, Jan-Peter Sowa, Dominic Meise, Ahmet Burak Ozbay. Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease Alimentary Pharmacology & Therapeutics 2020; 52(7): 1185 doi: 10.1111/apt.16016
205
Amedeo Lonardo, Stefano Ballestri, Alessandro Mantovani, Fabio Nascimbeni, Simonetta Lugari, Giovanni Targher. Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?Digestive and Liver Disease 2019; 51(4): 462 doi: 10.1016/j.dld.2018.12.014
206
Miaoting Yang, Zhijuan Chen, Shijian Xiang, Fan Xia, Waijiao Tang, Xiaorui Yao, Benjie Zhou. Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δBMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-03164-3
207
Ji-Youn Kim, Yong-Moon Park, Gyu-Na Lee, Hyun Chul Song, Yu-Bae Ahn, Kyungdo Han, Seung-Hyun Ko, Houkai Li. Association between toothbrushing and non-alcoholic fatty liver diseasePLOS ONE 2021; 16(5): e0243686 doi: 10.1371/journal.pone.0243686
208
Chang-hua Zhang, Bu-gao Zhou, Jun-qing Sheng, Yang Chen, Ying-qian Cao, Chen Chen. Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategiesPharmacological Research 2020; 159: 104984 doi: 10.1016/j.phrs.2020.104984
209
Egor V. Kalinin, Yaroslava M. Chalenko, Elena V. Sysolyatina, Konstantin Y. Midiber, Alexey M. Gusarov, Olga I. Kechko, Alexandra A. Kulikova, Ludmila M. Mikhaleva, Andrey Ya. Mukhachev, Yaroslav M. Stanishevskyi, Vladimir A. Mitkevich, Konstantin A. Sobyanin, Svetlana A. Ermolaeva. Bacterial hepatocyte growth factor receptor agonist stimulates hepatocyte proliferation and accelerates liver regeneration in a partial hepatectomy rat modelDrug Development Research 2021; 82(1): 123 doi: 10.1002/ddr.21737
210
Esther Rey, Elvira del Pozo-Maroto, Patricia Marañón, Brittany Beeler, Yaiza García-García, Pedro Landete, Stephania C. Isaza, Ramón Farré, Carmelo García-Monzón, Isaac Almendros, Águeda González-Rodríguez. Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep ApneaFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00450
211
Dimitrios Tsilingiris, Evangelia Tzeravini, Chrysi Koliaki, Maria Dalamaga, Alexander Kokkinos. The Role of Mitochondrial Adaptation and Metabolic Flexibility in the Pathophysiology of Obesity and Insulin Resistance: an Updated OverviewCurrent Obesity Reports 2021; 10(3): 191 doi: 10.1007/s13679-021-00434-0
212
Tudor Mocan, Dong Wook Kang, Billy J. Molloy, Hyeonho Jeon, Zeno A. Spârchez, Diren Beyoğlu, Jeffrey R. Idle. Plasma fetal bile acids 7α-hydroxy-3-oxochol-4-en-24-oic acid and 3-oxachola-4,6-dien-24-oic acid indicate severity of liver cirrhosisScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87921-5
213
Kavita Jadhav, Taylor S. Cohen. Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASHFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.592157
214
Graciela K. Krolow, Eduardo Garcia, Fabiola Schoor, Fernanda B.S. Araujo, Gabriela P. Coral. Obstructive sleep apnea and severity of nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2021; 33(8): 1104 doi: 10.1097/MEG.0000000000001920
215
Andrea Gonzalez, Mayalen Valero-Breton, Camila Huerta-Salgado, Oscar Achiardi, Felipe Simon, Claudio Cabello-Verrugio. Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysisEuropean Journal of Translational Myology 2021;  doi: 10.4081/ejtm.2020.9630
216
Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Natalia Wasilewska, Dariusz Marek Lebensztejn. From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?Journal of Clinical Medicine 2021; 10(5): 924 doi: 10.3390/jcm10050924
217
Maria Wallert, Lisa Börmel, Stefan Lorkowski. Inflammatory Diseases and Vitamin E—What Do We Know and Where Do We Go?Molecular Nutrition & Food Research 2021; 65(1): 2000097 doi: 10.1002/mnfr.202000097
218
Jae Hyun Yoon, Chung Hwan Jun, Jeong Han Kim, Eileen L. Yoon, Byung Seok Kim, Jeong Eun Song, Ki Tae Suk, Moon Young Kim, Seong Hee Kang. Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of AlcoholJournal of Korean Medical Science 2021; 36(21) doi: 10.3346/jkms.2021.36.e145
219
Cindy X. Cai, Stella Carlos, Pejman Solaimani, Bansari J. Trivedi, Chuong Tran, Shobha Castelino-Prabhu. Dietary Interventions in Liver Disease2019; : 357 doi: 10.1016/B978-0-12-814466-4.00029-X
220
Neil R. Chappell, Beth Zhou, Pardis Hosseinzadeh, Amy Schutt, William E. Gibbons, Chellakkan S. Blesson. Hyperandrogenemia alters mitochondrial structure and function in the oocytes of obese mouse with polycystic ovary syndromeF&S Science 2021; 2(1): 101 doi: 10.1016/j.xfss.2020.12.001
221
Jing Guo, Ingolf Sack, Stephan Rodrigo Marticorena Garcia. Liver Elastography2020; : 69 doi: 10.1007/978-3-030-40542-7_6
222
Alexandra Lasch, Philip Marx-Stoelting, Albert Braeuning, Dajana Lichtenstein. More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cellsArchives of Toxicology 2021; 95(4): 1397 doi: 10.1007/s00204-021-02997-2
223
Vinod K. Rustgi, You Li, Tina John, Carolyn Catalano, Mohamed I. Elsaid. Health Care Resource Use and Cost Burden of Chronic Kidney Disease in Patients With Chronic Liver Disease: A Real‐World Claims AnalysisHepatology Communications 2020; 4(10): 1404 doi: 10.1002/hep4.1573
224
Michael G. Ross, Mina Desai. Genetic Disorders and the Fetus2021; : 214 doi: 10.1002/9781119676980.ch5
225
Fatemeh Haidari, Abdollah Hojhabrimanesh, Bizhan Helli, Seyed-Saeed Seyedian, Kambiz Ahmadi-Angali, Behnaz Abiri. A hypocaloric high-protein diet supplemented with β-cryptoxanthin improves non-alcoholic fatty liver disease: a randomized controlled trialBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01502-w
226
Nirmalya Sinha, Saptarshi Mukhopadhyay, Manabendra Sau. Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesityIndian Journal of Gastroenterology 2020; 39(1): 75 doi: 10.1007/s12664-020-01020-3
227
Nigel S. Cook, Julie Cave, Anke-Peggy Holtorf. Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient NeedsFrontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00082
228
Maxime Tremblay, Nicolas Perrot, Nooshin Ghodsian, Émilie Gobeil, Christian Couture, Patricia L Mitchell, Sébastien Thériault, Benoit J Arsenault. Circulating Galectin-3 Levels Are Not Associated With Nonalcoholic Fatty Liver Disease: A Mendelian Randomization StudyThe Journal of Clinical Endocrinology & Metabolism 2021; 106(8): e3178 doi: 10.1210/clinem/dgab144
229
Hossein Saneian, Leila Khalilian, Motahar Heidari-Beni, Majid Khademian, Fatemeh Famouri, Peyman Nasri, Akbar Hassanzadeh, Roya Kelishadi. Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trialJournal of Pediatric Endocrinology and Metabolism 2021; 34(7): 897 doi: 10.1515/jpem-2020-0642
230
Andrew Yang, Melinda Nguyen, Irene Ju, Anthony Brancatisano, Brendan Ryan, David van der Poorten. Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgeryScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93294-6
231
Karn Wijarnpreecha, Melissa Scribani, Pascale Raymond, Denise M Harnois, Andrew P Keaveny, Aijaz Ahmed, Donghee Kim. PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States Journal of Gastroenterology and Hepatology 2020; 35(10): 1789 doi: 10.1111/jgh.15045
232
Pichamol Jirapinyo, Thomas R. McCarty, Russell D. Dolan, Raj Shah, Christopher C. Thompson. Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology 2021;  doi: 10.1016/j.cgh.2021.03.017
233
Yogesh Yadav, Wing-Kin Syn, Rita Basu. Evolving Management Strategies for Nonalcoholic Fatty Liver Disease–Targeting Primary Care PhysiciansDiabetes Technology & Therapeutics 2019; 21(11): 611 doi: 10.1089/dia.2019.0158
234
Seyed Mostafa Parizadeh, Seyed Alireza Parizadeh, Mohadese Alizade-Noghani, Reza Jafarzadeh-Esfehani, Maryam Ghandehari, Ali Mottaghi-Moghaddam, Fatemeh Goldani, Majid Khazaei, Majid Ghayour-Mobarhan, Gordon A. Ferns, Seyed Mahdi Hassanian, Amir Avan. Association between non-alcoholic fatty liver disease and colorectal cancerExpert Review of Gastroenterology & Hepatology 2019; 13(7): 633 doi: 10.1080/17474124.2019.1617696